Russia Claims To Repel American Warship, US Denies

Russia claims to repel American warship, US denies. The tussle between Russia and the US Navy has increased in the sea of ​​Japan.

Russia has said that its warship in the sea of ​​Japan drove an American naval ship carrying out illegal activities.

Whereas the US Navy has categorically denied any such activity of any of its ships and has accused Russia of fabrication.

According to Moscow, on Tuesday, Russian destroyer Admiral Vinogradov verbally warned USS John S. McCain, a US Navy warship equipped with missiles, to stay out of its territory.

Also asked to return to neutral waters. Russia says that the battleship of the Pacific Fleet has gone to ‘Peter the Great Gulf’ in pursuit of the American destroyer ship.

He claimed that the American warship had penetrated into the Russian waters late night two kilometers inside.

On the other hand, the US Navy maintains that their warships have remained in international waters the entire time. They have completely rejected Russia’s claims.

US Navy Seventh Fleet spokesman Lt. Joie Kelly said the US never secretly infiltrated anyone’s territory. We reject Russia’s Navy claims.

He said that Russia has lied in relation to our Freedom of Navigation campaign. It is noteworthy that such incidents are rare in maritime areas.

But now it can increase diplomatic and military relations between Russia and America.

Russia claims, Sputnik V will be 95 percent effective, cheaper than American vaccine

Russia has claimed that its corona vaccine Sputnik-V has been found to be more than 95 percent effective and cheaper than others.

This has been claimed by those who developed the vaccine based on a second interim analysis of clinical data.

The price of two doses of Sputnik-V in the international market will be around $ 20 (about Rs 1,500) and it will be given free to the people of Russia.

There will also be no need for extremely cold cold storage for its distribution.

At the same time, the cost of two doses of the vaccine of American company Pfizer will be around Rs 2,500.

Russia’s Ministry of Health, Government Gamalaya Research Center, and Russian Direct Investment Fund (RDIF) said in a statement .

On Tuesday that a second interim analysis showed that it was 91.4 percent effective 28 days after the first dose and 95 days after 42 days. Percent.

Approximately two thousand people were given this dose during the trial, based on which this assessment has been done.